Erratum: Genetic immunization in the lung induces potent local and systemic immune responses (Proceedings of the National Academy of Sciences of the United States of America (2010) 107 (22213-22218) DOI: 10.1073/pnas.1015536108);Genetic immunization in the lung induces potent local and systemic immune responses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 51, 2010, Pages 22213-22218

  Song, Kaimei ^a   Boltona, Diane L ^a   Wilson, Robert L ^b   Camp, Jeremy V ^b   Bao, Saran ^a   Mattapallil, Joseph J ^c   Herzenberg, Leonore A ^d   Herzenberg, Leonard A ^d   Andrews, Charla A ^a   Sadoff, Jerald C ^e   Goudsmit, Jaap ^f   Pau, Maria Grazia ^f   Seder, Robert A ^a   Kozlowski, Pamela A ^b   Nabel, Gary J ^a   Roederer, Mario ^a,b   Rao, Srinivas S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d STANFORD UNIVERSITY   (United States)

^e AERAS Global TB Foundation   (United States)

^f CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GAG PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; MYCOBACTERIUM ANTIGEN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG POTENCY; FERRET; GENETIC IMMUNIZATION; HUMORAL IMMUNITY; IMMUNOGENICITY; INFLUENZA A (H5N1); MUCOSAL IMMUNITY; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALIA; AVIAN INFLUENZA VIRUS; MUSTELA; PRIMATES;

EID: 78650673766     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1100067108     Document Type: Erratum

References (24)

1. Barouch DH (2010) Novel adenovirus vector-based vaccines for HIV-1. Curr Opin HIV AIDS 5:386-390.
2. Einarsdottir T, Lockhart E, Flynn JL (2009) Cytotoxicity and secretion of gamma interferon are carried out by distinct CD8 T cells during Mycobacterium tuberculosis infection. Infect Immun 77:4621-4630.
3. Sud D, Bigbee C, Flynn JL, Kirschner DE (2006) Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection. J Immunol 176:4296-4314.
4. Collins PL, Graham BS (2008) Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 82:2040-2055.
5. Sharma JM (1999) Introductiontopoultry vaccinesandimmunity. Adv Vet Med 41:481-494.
6. Cutts FT, Clements CJ, Bennett JV (1997) Alternative routes of measles immunization: A review. Biologicals 25:323-338.
7. Letvin NL, et al. (2004) Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. J Virol 78:7490-7497.
8. Brand P, et al. (1999) Intrapulmonary distribution of deposited particles. J Aerosol Med 12:275-284.
9. Graham BS, et al.; Vaccine Research Center 004 Study Team (2006) Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J Infect Dis 194:1650-1660.
10. Seder RA, Darrah PA, Roederer M (2008) T-cell quality in memory and protection: Implications for vaccine design. Nat Rev Immunol 8:247-258.
11. Darrah PA, et al. (2007) Multifunctional TH1 cells define a correlate of vaccinemediated protection against Leishmania major. Nat Med 13:843-850.
12. Barouch DH, Nabel GJ (2005) Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum Gene Ther 16:149-156.
13. Radosevic K, et al. (2007) Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 75:4105-4115.
14. Gao W, et al. (2006) Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 80:1959-1964.
15. Svitek N, von Messling V (2007) Early cytokine mRNA expression profiles predict Morbillivirus disease outcome in ferrets. Virology 362:404-410.
16. Sumida SM, et al. (2005) Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. J Immunol 174:7179-7185.
17. Abbink P, et al. (2007) Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol 81:4654-4663.
18. Gallichan WS, Rosenthal KL (1995) Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 13:1589-1595.
19. Maecker HT, et al. (2001) Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 255:27-40.
20. Schmittgen TD, et al. (2000) Quantitative reverse transcription- polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods. Anal Biochem 285:194-204.
21. Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V (2008) Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 376:53-59.
22. Letvin NL, et al. (2007) No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J Virol 81:12368-12374.
23. Sprangers MC, et al. (2003) Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: Addressing preexisting immunity to vaccine and gene therapy vectors. J Clin Microbiol 41:5046-5052.
24. Yang ZY, et al. (2007) Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 317:825-828.